Current PCI Landscape and Opportunities for Improvement

An overview of the landscape, contemporary data, quality measures, and technologic trends that will guide complex CAD cases toward complete revascularization.

By George Vetrovec, MD, MACC, MSCAI

Evolving Evidence for Protected PCI With Impella® to Treat High-Risk Complex CAD Patients

PROTECT clinical studies consistently demonstrate MACCE reduction at 90 days.

By Seth Bilazarian, MD, FACC, FSCAI

Renal Protection During Impella®-Supported PCI in Patients With High-Risk Complex Coronary Artery Disease

By Michael P. Flaherty, MD, PhD, FACC, FSCAI

The Benefit of Complete Revascularization and Efficacy of Complete Revascularization in a Single Setting

Comprehensive and well-documented data demonstrate that complete revascularization has distinct clinical advantages, especially in patients with complex multivessel disease.

By Rajan Patel, MD, FACC, FAHA, FSCAI

The Opportunity for Increased Quality Care and Shared Savings With the Impella® Heart Pump

By Charles Simonton, MD